Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1365339.RA3vmIGVu4lV8GY0qrWJ9dBkFgte90N8SavL2stN14Ozk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1365339.RA3vmIGVu4lV8GY0qrWJ9dBkFgte90N8SavL2stN14Ozk130_assertion type Assertion NP1365339.RA3vmIGVu4lV8GY0qrWJ9dBkFgte90N8SavL2stN14Ozk130_head.
- NP1365339.RA3vmIGVu4lV8GY0qrWJ9dBkFgte90N8SavL2stN14Ozk130_assertion description "[Germline mutations of BRCA2 are predicted to account for approximately 35% of families with multiple case, early onset female breast cancer, and they are also associated with an increased risk of male breast cancer, ovarian cancer, prostate cancer and pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1365339.RA3vmIGVu4lV8GY0qrWJ9dBkFgte90N8SavL2stN14Ozk130_provenance.
- NP1365339.RA3vmIGVu4lV8GY0qrWJ9dBkFgte90N8SavL2stN14Ozk130_assertion evidence source_evidence_literature NP1365339.RA3vmIGVu4lV8GY0qrWJ9dBkFgte90N8SavL2stN14Ozk130_provenance.
- NP1365339.RA3vmIGVu4lV8GY0qrWJ9dBkFgte90N8SavL2stN14Ozk130_assertion SIO_000772 8988179 NP1365339.RA3vmIGVu4lV8GY0qrWJ9dBkFgte90N8SavL2stN14Ozk130_provenance.
- NP1365339.RA3vmIGVu4lV8GY0qrWJ9dBkFgte90N8SavL2stN14Ozk130_assertion wasDerivedFrom befree-2016 NP1365339.RA3vmIGVu4lV8GY0qrWJ9dBkFgte90N8SavL2stN14Ozk130_provenance.
- NP1365339.RA3vmIGVu4lV8GY0qrWJ9dBkFgte90N8SavL2stN14Ozk130_assertion wasGeneratedBy ECO_0000203 NP1365339.RA3vmIGVu4lV8GY0qrWJ9dBkFgte90N8SavL2stN14Ozk130_provenance.